Literature DB >> 385209

Clinical pharmacokinetics of frusemide.

R E Cutler, A D Blair.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 385209     DOI： 10.2165/00003088-197904040-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  60 in total

1.  A simplified assay of furosemide in plasma and urine by high-pressure liquid chromatography.

Authors:  K Carr; A Rane; J C Frölich
Journal:  J Chromatogr       Date:  1978-05-01

2.  Malabsorption of frusemide caused by phenytoin.

Authors:  A Fine; I S Henderson; D R Morgan; W J Tilstone
Journal:  Br Med J       Date:  1977-10-22

3.  Pharmacokinetics of frusemide in chronic renal failure.

Authors:  A Fine; A C Kennedy; W J Tilstone
Journal:  Proc Eur Dial Transplant Assoc       Date:  1976

4.  Diuretic properties of furosemide in renal disease.

Authors:  R G Muth
Journal:  Ann Intern Med       Date:  1968-08       Impact factor: 25.391

5.  Pharmacokinetics of orally administered furosemide.

Authors:  M R Kelly; R E Cutler; A W Forrey; B M Kimpel
Journal:  Clin Pharmacol Ther       Date:  1974-02       Impact factor: 6.875

6.  Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid.

Authors:  J H Stewart; K D Edwards
Journal:  Br Med J       Date:  1965-11-27

7.  Effect of dosage regimen on natriuretic response to furosemide.

Authors:  T W Wilson; K J Falk; J L Labelle; K B Nguyen
Journal:  Clin Pharmacol Ther       Date:  1975-08       Impact factor: 6.875

8.  Pharmacokinetic disposition and protein binding of furosemide in newborn infants.

Authors:  J V Aranda; J Perez; D S Sitar; J Collinage; A Portuguez-Malavasi; B Duffy; C Dupont
Journal:  J Pediatr       Date:  1978-09       Impact factor: 4.406

9.  Effects of furosemide in the newborn.

Authors:  W C Woo; C Dupont; J Collinge; J V Aranda
Journal:  Clin Pharmacol Ther       Date:  1978-03       Impact factor: 6.875

10.  Furosemide kinetics in renal failure.

Authors:  W J Tilstone; A Fine
Journal:  Clin Pharmacol Ther       Date:  1978-06       Impact factor: 6.875
View more
  29 in total

1.  Drug treatment of cardiac failure.

Authors:  M R Achong; C R Kumana
Journal:  Can Fam Physician       Date:  1982-01       Impact factor: 3.275

Review 2.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

3.  Diuretic effect and disposition of furosemide in cystic fibrosis.

Authors:  J Prandota; I J Smith; B C Hilman; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Renal transport kinetics of furosemide in the isolated perfused rat kidney.

Authors:  L J Lee; J A Cook; D E Smith
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

5.  Plasma protein binding of furosemide in the elderly.

Authors:  G M Pacifici; A Viani; H U Schulz; H J Frercks
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Physiological modelling of renal drug clearance.

Authors:  I Janků
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  The pharmacokinetics of frusemide are influenced by age.

Authors:  F Andreasen; U Hansen; S E Husted; J A Jansen
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

8.  Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism.

Authors:  M G Lee; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

9.  Urinary excretion and diuretic action of furosemide in rats: increased response to the urinary excretion rate of furosemide in rats with acute renal failure.

Authors:  T Kikkoji; A Kamiya; K Inui; R Hori
Journal:  Pharm Res       Date:  1988-11       Impact factor: 4.200

10.  Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis.

Authors:  M M Hammarlund; L K Paalzow; B Odlind
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.